Drug price history · CMS NADAC read 11 November 2026

What have pharmacies paid for Fosfomycin since 2013?

What pharmacies pay, not what you pay. Fosfomycin has 1 product in the CMS NADAC survey, 1 product with year-end prices in more than one year. NADAC is what pharmacies pay to acquire a drug, not what a patient is charged. Fosfomycin 3 GM Sachet: $69.86 per unit at the 2021 survey and $26.37 at 2026 (−62%, thin).
Not medical or financial advice. This page reports what pharmacies pay to acquire a drug, from the CMS NADAC survey. It is not what you will be charged, and it says nothing about which medicine is right for you. Ask your pharmacist or prescriber.
Fosfomycin1 product in NADAC
1product with a price history
  1. Fosfomycin has 1 product in the CMS NADAC survey, 1 product with year-end prices in more than one year. NADAC is what pharmacies pay to acquire a drug, not what a patient is charged.
  2. 1 of the changes rest on fewer than 3 priced NDCs at one end and are marked thin: a median over one or two NDCs reflects which NDCs were priced as much as a price movement.
  3. This is a per-unit acquisition cost, not a retail price, a copay or an insurer's price, and it says nothing about why a price moved.

Fosfomycin 3 GM Sachet

Generic

$69.86 per unit at the 2021 year-end survey (2 NDCs) and $26.37 at the 2026 survey (11 NDCs): −62%, a thin comparison.

$0$69.862021: median $69.86 per unit, 2 NDCs priced2022: median $59.91 per unit, 5 NDCs priced2023: median $43.95 per unit, 6 NDCs priced2024: median $41.92 per unit, 4 NDCs priced2025: median $35.54 per unit, 6 NDCs priced2026: median $26.37 per unit, 11 NDCs priced202120222023202420252026
year-end median across the NDCs pricedlowest to highest NDC
Year-end surveyMedian per unitLowest to highestNDCs priced
2021 (2021-12-29)$69.862
2022 (2022-12-28)$59.915
2023 (2023-12-27)$43.956
2024 (2024-12-25)$41.924
2025 (2025-12-31)$35.546
2026 (2026-11-11)$26.3711

CMS National Average Drug Acquisition Cost, year-end surveys 2013 to 2026. A pharmacy acquisition cost, not a retail price. About NADAC.

How many companies make Fosfomycin?

The FDA Orange Book lists no generic maker as marketed for Fosfomycin. The acquisition costs above are what pharmacies pay across the NDCs priced; the Orange Book count is a separate record and this page does not say that more makers lowered a price. See each maker and the patents still listed on OmniRx.

Where can you go from this record?

Open it in the check to search another drug, or see the CMS pharmacy pricing page for what NADAC measures. For who makes the generic and which patents are listed, see the generic competition check for Fosfomycin on OmniRx. To check whether a drug is in shortage, see the FDA drug shortages page.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the CMS pharmacy pricing page, year-end surveys 2013 to 2026 (latest 11 November 2026).